UBS Group AG Files Schedule 13G Disclosing 6.74% Position in AMRZ
Rhea-AI Filing Summary
UBS Group AG, through its UBS Asset Management division, reports beneficial ownership of 38,197,652 ordinary shares of Amrize Ltd, representing 6.74% of the class. UBS Asset Management reports sole voting power over 35,252,775 shares and shared dispositive power over 38,197,652 shares, indicating voting control for most of its reported position.
The filing identifies UBS Asset Management (Americas) LLC and multiple UBS AM affiliates as included in the disclosure and states accounts are managed on a discretionary basis with rights to dividends or sale proceeds. The filer certifies the holdings were acquired in the ordinary course of business and were not acquired to change or influence control of the issuer.
Positive
- Disclosed a material beneficial stake of 38,197,652 shares (6.74%)
- Reported sole voting power for 35,252,775 shares
- Filing states holdings are managed on a discretionary basis and not held to influence control
Negative
- None.
Insights
TL;DR: UBS reports a material 6.74% passive stake with substantial sole voting power but states it is not seeking control.
UBS Asset Management's disclosed position of 38,197,652 shares exceeds the 5% reporting threshold, making the holding material for investors to note. The combination of 35,252,775 shares with sole voting power and full dispositive power reported indicates UBS can direct voting on most of the position even though the filing classifies the holdings as managed in the ordinary course. This disclosure may affect market perception of shareholder concentration, but the filer explicitly certifies the stake is not held to influence control.
TL;DR: Schedule 13G filing indicates passive disclosure, lists UBS AM affiliates, and includes a certification against control-seeking intent.
The submission identifies UBS Asset Management (Americas) LLC and a range of UBS AM affiliates as part of the reporting group and classifies the relevant subsidiary as an investment adviser. Item 10 contains a certification that the securities were acquired and are held in the ordinary course of business and not to change or influence control. The filing also states, to the filers knowledge, no single account holds more than 5% of the outstanding securities, which addresses potential aggregation concerns under regulatory rules.
FAQ
How many Amrize Ltd (AMRZ) shares does UBS report owning?
What voting and dispositive powers does UBS report for AMRZ?
Does UBS state it is seeking to influence control of Amrize Ltd?
Which UBS entity is identified as the subsidiary that acquired the securities?
Does any single UBS account hold more than 5% of Amrize's outstanding shares?